https://scholars.lib.ntu.edu.tw/handle/123456789/633133
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHIA-CHI WANG | en_US |
dc.contributor.author | JIA-HORNG KAO | en_US |
dc.date.accessioned | 2023-06-27T05:11:55Z | - |
dc.date.available | 2023-06-27T05:11:55Z | - |
dc.date.issued | 2023-04-01 | - |
dc.identifier.issn | 02709139 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/633133 | - |
dc.relation.ispartof | Hepatology | en_US |
dc.title | Letter to the Editor: Learning more about the safety of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma | en_US |
dc.type | other | en_US |
dc.identifier.doi | 10.1097/HEP.0000000000000009 | - |
dc.identifier.pmid | 36626618 | - |
dc.identifier.scopus | 2-s2.0-85150699717 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85150699717 | - |
dc.relation.journalvolume | 77 | en_US |
dc.relation.journalissue | 4 | en_US |
dc.relation.pageend | E83 | en_US |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_1843 | - |
item.cerifentitytype | Products | - |
item.openairetype | other | - |
item.grantfulltext | none | - |
crisitem.author.dept | Veterinary Medicine | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0002-1272-1513 | - |
crisitem.author.orcid | 0000-0002-2442-7952 | - |
crisitem.author.parentorg | College of Bioresources and Agriculture | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。